The transformative impact of calorimetry-focused 3D phenotype assays—strengthening diagnostics in drug discovery and personalized medicine

Broad inadequacies in a widespread biological concept that affects cancer research could be significantly deflecting the aim of such targeted drugs, according to a new study

The new SCiLS Cloud and SCiLS Lab software solutions, now with MultiVendor Support, bring innovative software features to mass spectrometry imaging applications

Drug zeroes in on mutated nuclear receptors found in cancer, leaves normal proteins alone

Scientists have created a new way of screening compounds that is more sensitive than existing methods, opening up the possibility of finding new drugs for many diseases

CODEx streamlines the analysis of therapeutic area-specific literature data to assess a new drug candidate’s likelihood of regulatory and commercial success

In a recent study, scientists report that a drug called "URMC-099" reversed liver inflammation, injury, and scarring in animals fed a diet high in fat, sugar, and cholesterol

The findings, published July 27 in Cell, reveal for the first time components of a G protein–coupled receptor (GPCR) named rhodopsin bound to a signaling molecule called arrestin, both crucial pieces of the body’s intricate cellular communication network

Surprising new mechanism for attaching chemical tracers discovered by team at Berkeley Lab, UC Berkeley

Early phase drug discovery research requires the highest level of accurate and reproducible testing in order to give you the proof to move confidently forward